<DOC>
	<DOCNO>NCT02957851</DOCNO>
	<brief_summary>To assess effect 3 consecutive day one-hour administration Nitrous Oxide/Oxygen 50 % /50 % ( EMONO ) versus placebo Oxygen/Nitrogen 22 % /78 % ( synthetic medical air ) , add-on therapy chronic analgesic treatment , average pain intensity patient chronic peripheral neuropathic pain . A total 250 randomise patient include participate centre , i.e. , 125 randomise patient 2 study group treatment</brief_summary>
	<brief_title>EMONO Treatment Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<criteria>Patients mean pain intensity 4 9 assessed daily Numerating Rating Scale 7 day period precede inclusion spite administration usual pain treatment . Neuropathic pain last 3 month le 10 year Definite probable peripheral neuropathy legal incapacity patient another concomitant chronic pain ongoing major depression Chemotherapyinduced peripheral neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>